Target intelligence / Profile preview

Protein phosphatase 1D mRNA 3'-untranslated region (PPM1D mRNA 3'-UTR)

Target
PPM1D mRNA 3'-UTR
Molecular classification
mRNA, 3'-untranslated region, Regulatory RNA element
01

Overview

The Protein phosphatase 1D (PPM1D) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the PPM1D transcript, which encodes the WIP1 phosphatase, a member of the PP2C family (Source: UniProt, P49757). This region serves as a primary site for post-transcriptional control, containing binding motifs for several microRNAs such as miR-16 and miR-145 that negatively regulate PPM1D expression (Source: PubMed, PMID: 21150130, 25605116). PPM1D functions as an oncogene by dephosphorylating and inactivating key proteins in the DNA damage response pathway, including p53, Chk1, and p38 MAPK, thereby promoting cell survival and inhibiting apoptosis (Source: PubMed, PMID: 15184876). Overexpression or gain-of-function mutations in PPM1D are frequently observed in breast, ovarian, and lung cancers, often correlating with poor prognosis (Source: PubMed, PMID: 24403010). Therapeutic targeting of the 3'-UTR using antisense oligonucleotides (ASOs) or microRNA mimics aims to reduce PPM1D protein levels, effectively restoring the cell's ability to undergo p53-mediated cell cycle arrest or apoptosis in response to DNA damage (Source: PubMed, PMID: 28655774). This approach is particularly relevant for sensitizing tumor cells to conventional chemotherapy and radiotherapy.

Other names
WIP1 mRNA 3'-UTRProtein phosphatase magnesium-dependent 1 delta mRNA 3'-UTRPP2C-delta mRNA 3'-UTR
02

Mechanism of action

Inhibition of translation and induction of mRNA degradation via RNA interference or antisense binding.

03

Biological functions

Regulation of mRNA stabilityTranslation regulationNegative regulation of DNA damage responseCell cycle control
04

Disease associations

Breast cancerOvarian cancerNeuroblastomaColorectal cancerLung cancer
05

Safety considerations

Off-target effects of RNA-based therapeuticsPotential impairment of normal DNA damage repair in healthy tissuesDelivery challenges to target tumor cells
06

Interacting drugs

miR-16 mimics

3 more in the full profile.

07

Biomarkers

PPM1D mRNA expression levelsp53 mutation statusmiR-16 expression levels

Beyond the preview

Go deeper on Protein phosphatase 1D mRNA 3'-untranslated region (PPM1D mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1D mRNA 3'-untranslated region (PPM1D mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call